NCT03276286View on ClinicalTrials.gov

Nativis Voyager for Newly Diagnosed GBM

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 10, 2017

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Glioblastoma Multiforme
Interventions
DEVICE

Nativis Voyager

Nativis Voyager treatment combined with standard of care radiotherapy and temozolomide

Trial Locations (7)

33486

Boca Raton Regional Hospital, Boca Raton

78705

Cancer Care Collaborative, Austin

85718

Center for Neurosciences, Tucson

90404

John Wayne Cancer Institute @ Providence St Johns Health Center, Santa Monica

92024

California Cancer Care Associates, Encinitas

98101

Baylor Scott and White Health, Temple

06824

Associated Neurologists of Southern CT, PC, Fairfield

Sponsors

Lead Sponsor

Nativis, Inc.
All Listed Sponsors
lead

Nativis, Inc.

INDUSTRY